AA
CERO

AQR Arbitrage’s CERo Therapeutics CERO Stock Holding History

AQR Arbitrage’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$863K – 824
2023
Q2 		$863K Hold
40
– – 0.04% 378
2023
Q1 		$854K Sell
40
-141
-78% -$2.97M 0.03% 445
2022
Q4 		$3.74M Hold
181
– – 0.1% 291
2022
Q3 		$3.67M Hold
181
– – 0.08% 339
2022
Q2 		$3.64M Hold
181
– – 0.08% 319
2022
Q1 		$3.63M Buy
181
+15
+9% +$298K 0.09% 252
2021
Q4 		$3.29M Buy
+166
New +$3.3M 0.08% 249

Other funds holding CERO

MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

AQR Arbitrage's CERO Position: Q3 2023 in Review

AQR Arbitrage sold out of CERo Therapeutics (CERO) in Q3 2023, closing a stake of 40 shares — an estimated $863K sold.

AQR Arbitrage first reported a position in CERO in Q4 2021 and held it in 7 quarters. The position peaked at $3.74M in Q4 2022. 10 funds tracked by Wall St. Rank hold CERO as of Q3 2023.

  • AQR Arbitrage reported no remaining CERo Therapeutics position as of Q3 2023 after selling out during the quarter.
  • AQR Arbitrage sold 40 CERo Therapeutics shares in Q3 2023, an estimated $863K.
  • AQR Arbitrage first reported a position in CERo Therapeutics in Q4 2021 and held it in 7 quarters.
  • AQR Arbitrage's CERo Therapeutics position peaked at $3.74M in Q4 2022.
  • 10 funds tracked by Wall St. Rank held CERo Therapeutics as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.